News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
111,213 Results
Type
Article (7297)
Company Profile (25)
Press Release (103891)
Multimedia
Podcasts (1)
Webinars (1)
Section
Business (33257)
Career Advice (205)
Deals (5177)
Drug Delivery (10)
Drug Development (11313)
Employer Resources (11)
FDA (3066)
Job Trends (3146)
News (54472)
Policy (5855)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
Academia (726)
Academic (1)
Allergies (15)
Alliances (10895)
ALS (8)
Alzheimer's disease (196)
Antibody-drug conjugate (ADC) (13)
Approvals (3102)
Artificial intelligence (38)
Automation (10)
Bankruptcy (28)
Best Places to Work (2470)
BIOSECURE Act (1)
Biosimilars (5)
Biotechnology (17)
Bladder cancer (11)
Brain cancer (4)
Breast cancer (47)
Cancer (396)
Cardiovascular disease (26)
Career advice (187)
Career pathing (2)
CAR-T (49)
Cell therapy (96)
Cervical cancer (9)
Clinical research (8474)
Collaboration (172)
Compensation (4)
Complete response letters (5)
COVID-19 (730)
CRISPR (14)
C-suite (33)
Cystic fibrosis (20)
Data (370)
Depression (1)
Diabetes (25)
Diagnostics (3194)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (24)
Drug pricing (3)
Drug shortages (1)
Duchenne muscular dystrophy (19)
Earnings (9621)
Editorial (1)
Employer branding (3)
Employer resources (9)
Events (11823)
Executive appointments (111)
FDA (3237)
Featured Employer (5)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (90)
Gene editing (22)
Generative AI (3)
Gene therapy (148)
GLP-1 (112)
Government (998)
Grass and pollen (3)
Guidances (5)
Healthcare (2522)
Huntington's disease (1)
Immunology and inflammation (5)
Indications (3)
Infectious disease (764)
Inflammatory bowel disease (7)
Influenza (14)
Intellectual property (12)
Interviews (28)
IPO (1631)
IRA (1)
Job creations (804)
Job search strategy (176)
Kidney cancer (1)
Labor market (2)
Layoffs (39)
Leadership (1)
Legal (1153)
Liver cancer (10)
Lung cancer (71)
Lymphoma (28)
Machine learning (1)
Management (3)
Manufacturing (68)
MASH (5)
Medical device (1394)
Medtech (1394)
Mergers & acquisitions (3626)
Metabolic disorders (49)
Multiple sclerosis (3)
NASH (1)
Neurodegenerative disease (14)
Neuropsychiatric disorders (1)
Neuroscience (236)
NextGen: Class of 2025 (900)
Non-profit (612)
Northern California (304)
Now hiring (11)
Obesity (20)
Opinion (21)
Ovarian cancer (12)
Pain (7)
Pancreatic cancer (8)
Parkinson's disease (15)
Partnered (4)
Patents (23)
Patient recruitment (9)
Peanut (10)
People (9900)
Pharmaceutical (6)
Phase I (2959)
Phase II (3509)
Phase III (3044)
Pipeline (155)
Policy (5)
Postmarket research (401)
Preclinical (1558)
Press Release (28)
Prostate cancer (23)
Psychedelics (2)
Radiopharmaceuticals (39)
Rare diseases (58)
Real estate (2038)
Recruiting (4)
Regulatory (4062)
Reports (8)
Research institute (683)
Resumes & cover letters (21)
RSV (6)
Schizophrenia (1)
Series A (16)
Series B (10)
Service/supplier (1)
Sickle cell disease (7)
Southern California (261)
Spinal muscular atrophy (42)
Sponsored (8)
Startups (673)
State (1)
Stomach cancer (2)
Supply chain (9)
Tariffs (1)
The Weekly (1)
United States (3052)
Vaccines (112)
Venture capitalists (1)
Weight loss (11)
Women's health (3)
Date
Today (11)
Last 7 days (52)
Last 30 days (315)
Last 365 days (4759)
2025 (1200)
2024 (5176)
2023 (6183)
2022 (9767)
2021 (10177)
2020 (9678)
2019 (6802)
2018 (5158)
2017 (5566)
2016 (5539)
2015 (6146)
2014 (4852)
2013 (4294)
2012 (4523)
2011 (4607)
2010 (4115)
Location
Africa (132)
Alabama (10)
Alaska (1)
Arizona (33)
Arkansas (3)
Asia (6681)
Australia (1125)
California (713)
Canada (252)
China (38)
Colorado (36)
Connecticut (31)
Delaware (25)
Europe (15860)
Florida (93)
Georgia (19)
Idaho (6)
Illinois (45)
India (4)
Indiana (39)
Iowa (2)
Japan (22)
Kansas (21)
Kentucky (4)
Louisiana (1)
Maine (24)
Maryland (129)
Massachusetts (458)
Michigan (59)
Minnesota (33)
Missouri (34)
Montana (9)
Nebraska (3)
Nevada (3)
New Hampshire (7)
New Jersey (312)
New Mexico (8)
New York (225)
North Carolina (168)
North Dakota (2)
Northern California (304)
Ohio (58)
Oklahoma (3)
Oregon (3)
Pennsylvania (149)
Rhode Island (10)
South America (189)
South Carolina (3)
Southern California (261)
Tennessee (17)
Texas (184)
Utah (42)
Virginia (13)
Washington D.C. (10)
Washington State (102)
Wisconsin (10)
111,213 Results for "vector laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vector Laboratories Announces Partnership With British Biotech Innovator Etcembly
February 20, 2025
·
3 min read
Press Releases
Vector Laboratories Announces the Appointment of Ashley Scholz as Vice President of Marketing
February 24, 2025
·
2 min read
Business
Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus
Charles River Laboratories International, Inc. today announced a lentiviral vector contract development and manufacturing organization (CDMO) agreement.
June 25, 2024
·
4 min read
Press Releases
ViroCell Biologics Appoints Viral Vector Expert as Special Advisor
March 27, 2025
·
2 min read
Deals
Vector Laboratories Merges With Absolute Biotech, Significantly Expanding Capabilities as a Critical Component Manufacturer for Life Science Customers
Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, announced its intention to merge with Absolute Biotech, a unified company of multiple antibody-centric brands.
May 15, 2024
·
4 min read
Business
Vector Laboratories and Navinci Diagnostics Announce Strategic Collaboration to Develop Novel Spatial Proteomic Tools Enabling Biomarker Discovery
Vector Laboratories today announced that they have signed an agreement.
January 30, 2024
·
3 min read
Genetown
Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy
Charles River Laboratories International, Inc. today announced a plasmid DNA and retrovirus vector production program agreement.
June 17, 2024
·
4 min read
Press Releases
FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON BINDING AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
March 20, 2025
·
4 min read
Press Releases
CHO Plus Obtains U.S. Patent for Improved Production of Viral Vectors for Gene Therapy
March 19, 2025
·
2 min read
Genetown
Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the introduction of its Modular and Fast Track viral vector technology (tech) transfer frameworks.
May 30, 2024
·
4 min read
1 of 11,122
Next
